Based on ratings from 12 stock analysts, the Stericycle Inc stock price is expected to decrease by 0.89% in 12 months. This is calculated by using the average 12-month stock price forecast for Stericycle Inc. The lowest target is $60.86 and the highest is $62. Please note analyst price targets are not guaranteed and could be missed completely.
About 12 Wall Street analysts have assignedSRCL 5 buy ratings, 5 hold ratings, and 2 sell ratings. This means that analysts expect Stericycle Inc to hold. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on SRCL. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
These are the latest 20 analyst ratings of SRCL.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
Sean Dodge RBC Capital | Sector Perform | $62 | Downgrade | Jun 4, 2024 |
Jade Rahmani Keefe, Bruyette & Woods | Outperform | $142 | Maintains | Jun 4, 2024 |
Tobey Sommer Truist Securities | Hold | $62 | Maintains | Jun 4, 2024 |
Tobey Sommer Truist Securities | Hold | $50 | Maintains | Apr 29, 2024 |
David Manthey Baird | Neutral | $55 | Maintains | Apr 26, 2024 |
Sean Dodge RBC Capital | Outperform | $69 | Reiterates | Mar 7, 2024 |
John Mazzoni Wells Fargo | Underweight | $48 | Maintains | Mar 1, 2024 |
Sean Dodge RBC Capital | Outperform | $69 | Maintains | Feb 29, 2024 |
Tobey Sommer Truist Securities | Hold | $57 | Maintains | Feb 29, 2024 |
Michael Hoffman Stifel | Buy | $75 | Maintains | Feb 29, 2024 |
Sean Dodge RBC Capital | Outperform | $58 | Maintains | Nov 3, 2023 |
Michael Hoffman Stifel | Buy | $70 | Reiterates | Sep 1, 2023 |
Sean Dodge RBC Capital | Outperform | $66 | Reiterates | Jun 14, 2023 |
Sean Dodge RBC Capital | Outperform | $66 | Reiterates | Jun 2, 2023 |
Sean Dodge RBC Capital | Outperform | $66 | Reiterates | May 1, 2023 |
Tobey Sommer Truist Securities | Hold | $45 | Initiates | Apr 18, 2023 |
David Manthey Baird | Neutral | $53 | Downgrade | Feb 24, 2023 |
Sean Dodge RBC Capital | Outperform | $70 | Maintains | Aug 8, 2022 |
Berenberg | Hold | Downgrade | May 12, 2022 | |
David Manthey Baird | Outperform | $72 | Maintains | Feb 25, 2022 |
When did it IPO
1996
Staff Count
13,095
Country
United States
Sector/Industry
Industrials/Waste Management
CEO
Ms. Cindy J. Miller
Market Cap
$5.75B
In 2023, SRCL generated $2.66B in revenue, which was a decrease of -1.68% from the previous year. This can be seen as a signal that SRCL's business is declining, and its share price could be worth less in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Summary - WM (NYSE: WM) has completed its $7.2 billion acquisition of Stericycle, Inc. (NASDAQ: SRCL) at $62.00 per share. Stericycle will cease trading on NASDAQ on November 4, 2024.
Why It Matters - WM's acquisition of Stericycle for $7.2 billion enhances its market position and service offerings, potentially driving growth and affecting stock performance.
Summary - Stericycle, Inc. unveiled a new 110,000-square foot Hospital, Medical and Infectious Waste Incinerator facility in McCarran, Nevada, to meet the rising demand for medical waste disposal.
Why It Matters - The new facility enhances Stericycle's capacity to meet rising demand in medical waste disposal, potentially increasing revenue and market share, positively impacting stock performance.
Summary - Stericycle, Inc. (Nasdaq: SRCL) has been named one of America's Best Midsize Companies of 2024 by TIME and Statista, highlighting its status in medical waste management and information destruction.
Why It Matters - Stericycle's recognition as one of America's Best Midsize Companies boosts its reputation, potentially attracting investors and increasing stock demand.
Summary - Stericycle, Inc. (SRCL) is partnering with the Arbor Day Foundation to plant 45,000 trees across the U.S. and Canada, enhancing its environmental restoration efforts.
Why It Matters - Stericycle's partnership with the Arbor Day Foundation enhances its corporate social responsibility profile, potentially improving brand loyalty and attracting environmentally conscious investors.
Summary - Stericycle, Inc. has been named one of America's Greatest Workplaces and for Mental Wellbeing in 2024 by Newsweek and Plant-A Insights Group, highlighting its workplace culture.
Why It Matters - Stericycle's recognition for workplace excellence can enhance its reputation, attract top talent, and potentially improve employee productivity, positively impacting financial performance and investor confidence.
Summary - Kahn Swick & Foti, LLC is investigating Stericycle's proposed sale to Waste Management for $62 per share, focusing on the fairness of the transaction and process for shareholders.
Why It Matters - The investigation into Stericycle's sale may indicate potential issues with the deal's valuation or process, impacting shareholder confidence and stock performance.